FDA clears Merck's Keytruda for cancers with certain genetic traits
(Reuters) - Merck& Co's immunotherapy Keytruda chalked up another approval on Tuesday as the U.S. Food and Drug Administration said the cancer medicine can be used to treat children and adults who carry a specific genetic feature regardless of where the disease originated.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Cancer | Cancer & Oncology | Children | Food and Drug Administration (FDA) | Genetics | Health | Immunotherapy | Merck